The White House Office of the United States Trade Representative yesterday extended through Nov. 14 tariff exemptions for certain medical care products needed to address the COVID-19 pandemic while it considers “further extensions and/or modifications as appropriate.” AHA has urged the office to extend the exemptions, which were set to expire Sept. 30, to ensure hospitals and health systems have the supplies they need to safety and effectively care for all patients during the COVID-19 pandemic.

Related News Articles

Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…